✦ LIBER ✦

257 MAMMALIAN TARGET OF RAPAMYCIN: POTENTIAL ROLES IN PAIN MAINTENANCE

✍ Scribed by C.O. Asante; A.H. Dickenson

Book ID: 108487193
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 48 KB
Volume: 10
Category: Article
ISSN: 1090-3801
DOI: 10.1016/s1090-3801(06)60260-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mammalian target of rapamycin inhibitors

Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies

✍ David T. Teachey; Stephan A. Grupp; Valerie I. Brown 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

The mammalian target of rapamycin pathwa

The mammalian target of rapamycin pathway and its role in molecular nutrition regulation

✍ Jun Lian; Xiang-Hua Yan; Jian Peng; Si-Wen Jiang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 925 KB

## Abstract Mammalian target of rapamycin (mTOR) is a protein serine‐threonine kinase that functions as a central element in signaling pathway involved in control of cell growth and proliferation. mTOR exists in at least two distinct multi‐protein complexes, mTORC1 and mTORC2. mTOR kinase controls

The emerging role of mammalian target of

The emerging role of mammalian target of rapamycin inhibitors in the treatment of sarcomas

✍ Sushma Vemulapalli; Alain Mita; Yesid Alvarado; Kamalesh Sankhala; Monica Mita 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 225 KB

Expression of an activated mammalian tar

Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy

✍ Leri S. Faried; Ahmad Faried; Tatsuya Kanuma; Hiroshi Aoki; Takaaki Sano; Tomoko 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 667 KB

## Abstract Alterations of the Akt/mTOR pathway have been observed in numerous types of cancer, thus this pathway represents an exciting new target for molecular therapeutics. We investigated the expression of activated Akt (p‐Akt) and mTOR (p‐mTOR) in patients with adenocarcinoma of the cervix and